380 related articles for article (PubMed ID: 27879676)
1. Calcium Dyshomeostasis in Tubular Aggregate Myopathy.
Lee JM; Noguchi S
Int J Mol Sci; 2016 Nov; 17(11):. PubMed ID: 27879676
[TBL] [Abstract][Full Text] [Related]
2. ORAI1 Mutations with Distinct Channel Gating Defects in Tubular Aggregate Myopathy.
Böhm J; Bulla M; Urquhart JE; Malfatti E; Williams SG; O'Sullivan J; Szlauer A; Koch C; Baranello G; Mora M; Ripolone M; Violano R; Moggio M; Kingston H; Dawson T; DeGoede CG; Nixon J; Boland A; Deleuze JF; Romero N; Newman WG; Demaurex N; Laporte J
Hum Mutat; 2017 Apr; 38(4):426-438. PubMed ID: 28058752
[TBL] [Abstract][Full Text] [Related]
3. Calcium entry units (CEUs): perspectives in skeletal muscle function and disease.
Protasi F; Pietrangelo L; Boncompagni S
J Muscle Res Cell Motil; 2021 Jun; 42(2):233-249. PubMed ID: 32812118
[TBL] [Abstract][Full Text] [Related]
4. Tubular aggregate myopathy and Stormorken syndrome: Mutation spectrum and genotype/phenotype correlation.
Morin G; Biancalana V; Echaniz-Laguna A; Noury JB; Lornage X; Moggio M; Ripolone M; Violano R; Marcorelles P; Maréchal D; Renaud F; Maurage CA; Tard C; Cuisset JM; Laporte J; Böhm J
Hum Mutat; 2020 Jan; 41(1):17-37. PubMed ID: 31448844
[TBL] [Abstract][Full Text] [Related]
5. Mechanistic insights into store-operated Ca
Koenig X; Choi RH; Schicker K; Singh DP; Hilber K; Launikonis BS
Biochim Biophys Acta Mol Cell Res; 2019 Jul; 1866(7):1239-1248. PubMed ID: 30825472
[TBL] [Abstract][Full Text] [Related]
6. ORAI1 channel gating and selectivity is differentially altered by natural mutations in the first or third transmembrane domain.
Bulla M; Gyimesi G; Kim JH; Bhardwaj R; Hediger MA; Frieden M; Demaurex N
J Physiol; 2019 Jan; 597(2):561-582. PubMed ID: 30382595
[TBL] [Abstract][Full Text] [Related]
7. Role of STIM1/ORAI1-mediated store-operated Ca
Michelucci A; García-Castañeda M; Boncompagni S; Dirksen RT
Cell Calcium; 2018 Dec; 76():101-115. PubMed ID: 30414508
[TBL] [Abstract][Full Text] [Related]
8. Gain-of-function mutations in STIM1 and ORAI1 causing tubular aggregate myopathy and Stormorken syndrome.
Böhm J; Laporte J
Cell Calcium; 2018 Dec; 76():1-9. PubMed ID: 30243034
[TBL] [Abstract][Full Text] [Related]
9. CRAC channels and disease - From human CRAC channelopathies and animal models to novel drugs.
Feske S
Cell Calcium; 2019 Jun; 80():112-116. PubMed ID: 31009822
[TBL] [Abstract][Full Text] [Related]
10. Dominant mutations in ORAI1 cause tubular aggregate myopathy with hypocalcemia via constitutive activation of store-operated Ca²⁺ channels.
Endo Y; Noguchi S; Hara Y; Hayashi YK; Motomura K; Miyatake S; Murakami N; Tanaka S; Yamashita S; Kizu R; Bamba M; Goto Y; Matsumoto N; Nonaka I; Nishino I
Hum Mol Genet; 2015 Feb; 24(3):637-48. PubMed ID: 25227914
[TBL] [Abstract][Full Text] [Related]
11. STIM1 and ORAI1 mutations leading to tubular aggregate myopathies are sensitive to the Store-operated Ca
Riva B; Pessolano E; Quaglia E; Cordero-Sanchez C; Bhela IP; Topf A; Serafini M; Cox D; Harris E; Garibaldi M; Barresi R; Pirali T; Genazzani AA
Cell Calcium; 2022 Jul; 105():102605. PubMed ID: 35636153
[TBL] [Abstract][Full Text] [Related]
12. Filamin A Modulates Store-Operated Ca
Lopez JJ; Albarrán L; Jardín I; Sanchez-Collado J; Redondo PC; Bermejo N; Bobe R; Smani T; Rosado JA
Arterioscler Thromb Vasc Biol; 2018 Feb; 38(2):386-397. PubMed ID: 29284605
[TBL] [Abstract][Full Text] [Related]
13. Alteration of STIM1/Orai1-Mediated SOCE in Skeletal Muscle: Impact in Genetic Muscle Diseases and Beyond.
Conte E; Imbrici P; Mantuano P; Coppola MA; Camerino GM; De Luca A; Liantonio A
Cells; 2021 Oct; 10(10):. PubMed ID: 34685702
[TBL] [Abstract][Full Text] [Related]
14. STIM1 over-activation generates a multi-systemic phenotype affecting the skeletal muscle, spleen, eye, skin, bones and immune system in mice.
Silva-Rojas R; Treves S; Jacobs H; Kessler P; Messaddeq N; Laporte J; Böhm J
Hum Mol Genet; 2019 May; 28(10):1579-1593. PubMed ID: 30576443
[TBL] [Abstract][Full Text] [Related]
15. [Tubular aggregate myopathy and Stormorken syndrome].
Böhm J; Laporte J
Med Sci (Paris); 2018 Nov; 34 Hors série n°2():26-31. PubMed ID: 30418142
[TBL] [Abstract][Full Text] [Related]
16. The TAM-associated STIM1
Kim JH; Carreras-Sureda A; Didier M; Henry C; Frieden M; Demaurex N
Cell Calcium; 2022 Jul; 105():102615. PubMed ID: 35792400
[TBL] [Abstract][Full Text] [Related]
17. Functional analyses of STIM1 mutations reveal a common pathomechanism for tubular aggregate myopathy and Stormorken syndrome.
Peche GA; Spiegelhalter C; Silva-Rojas R; Laporte J; Böhm J
Neuropathology; 2020 Dec; 40(6):559-569. PubMed ID: 33073872
[TBL] [Abstract][Full Text] [Related]
18. Orai1 enhances muscle endurance by promoting fatigue-resistant type I fiber content but not through acute store-operated Ca2+ entry.
Carrell EM; Coppola AR; McBride HJ; Dirksen RT
FASEB J; 2016 Dec; 30(12):4109-4119. PubMed ID: 27587568
[TBL] [Abstract][Full Text] [Related]
19. Silencing of the Ca
Silva-Rojas R; Pérez-Guàrdia L; Lafabrie E; Moulaert D; Laporte J; Böhm J
Int J Mol Sci; 2022 Jun; 23(13):. PubMed ID: 35805973
[TBL] [Abstract][Full Text] [Related]
20. Constitutive activation of the calcium sensor STIM1 causes tubular-aggregate myopathy.
Böhm J; Chevessier F; Maues De Paula A; Koch C; Attarian S; Feger C; Hantaï D; Laforêt P; Ghorab K; Vallat JM; Fardeau M; Figarella-Branger D; Pouget J; Romero NB; Koch M; Ebel C; Levy N; Krahn M; Eymard B; Bartoli M; Laporte J
Am J Hum Genet; 2013 Feb; 92(2):271-8. PubMed ID: 23332920
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
